SCHEMBL1865038

SCHEMBL1865038

CSc1ncc2c(Cl)[c]ccc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 7/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RPS6KA5 O75582 1/20 0.35
LMNA P02545 4/20 0.34
HTT P42858 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AHR P35869 1/20 0.33
NTRK1 P04629 1/20 0.32
HASPIN Q8TF76 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24804424 0.73 KDM4E (0.50) MEN1KMT2AKDM4EL3MBTL1NPSR1
SCHEMBL15564864 0.73 MEN1 (0.42) MEN1KMT2AKDM4EL3MBTL1NPSR1
SCHEMBL1571397 0.71 MEN1 (0.44) MEN1KMT2AKDM4EL3MBTL1NPSR1
SCHEMBL15565637 0.68 CYP2A6 (0.40) MEN1KMT2AKDM4EL3MBTL1TDP1
SCHEMBL31083305 0.67 BACE1 (0.43) MEN1KMT2AKDM4EL3MBTL1NPSR1
SCHEMBL31235431 0.67 HASPIN (0.42) MEN1KMT2AKDM4EL3MBTL1SMN1; SMN2
SCHEMBL26708748 0.67 KMT2A (0.42) MEN1KMT2AKDM4ESMN1; SMN2RPS6KA5
SCHEMBL31235160 0.67 KMT2A (0.42) MEN1KMT2AKDM4ESMN1; SMN2RPS6KA5
SCHEMBL24558656 0.66 MEN1 (0.45) MEN1KMT2AKDM4EL3MBTL1NPSR1
SCHEMBL1571643 0.65 MEN1 (0.35) MEN1KMT2AKDM4EL3MBTL1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079988-A9 QUINAZOLINES FOR PDK1 INHIBITION NOVARTIS AG (CH) 2011-05-12 WO disclosed